Compare UTMD & ACRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UTMD | ACRE |
|---|---|---|
| Founded | 1978 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 226.1M | 261.9M |
| IPO Year | 1994 | 2011 |
| Metric | UTMD | ACRE |
|---|---|---|
| Price | $72.77 | $4.65 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.38 |
| AVG Volume (30 Days) | 21.7K | ★ 471.2K |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | 1.91% | ★ 11.58% |
| EPS Growth | N/A | ★ 26.17 |
| EPS | ★ 1.66 | 1.35 |
| Revenue | $38,520,000.00 | ★ $54,833,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $16.28 |
| P/E Ratio | $43.25 | ★ $3.43 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $53.66 | $4.14 |
| 52 Week High | $75.75 | $5.89 |
| Indicator | UTMD | ACRE |
|---|---|---|
| Relative Strength Index (RSI) | 56.15 | 51.17 |
| Support Level | $68.93 | $4.60 |
| Resistance Level | $74.75 | $4.69 |
| Average True Range (ATR) | 1.53 | 0.10 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 71.01 | 42.40 |
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
Ares Commercial Real Estate Corp is a specialty finance company and a real estate investment trust mainly engaged in originating and investing in commercial real estate (CRE) loans and related investments. It operates in one segment, namely originating and managing a diversified portfolio of CRE debt-related investments. The company recognizes the majority of its revenues in the form of interest income, which it receives from loans.